Indian Immunologicals receives approval for measles-rubella vaccine

Leading vaccine manufacturer Indian Immunologicals Ltd (IIL) on Monday announced that it has received approval from the Drugs Controller General of India and State Drug Control Administration for manufacturing of measles-rubella (MR) vaccine.


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *